OVERSEA CHINESE BANKING Corp Ltd bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 29,795 shares of the company’s stock, valued at approximately $3,825,000.
Other hedge funds also recently added to or reduced their stakes in the company. Gables Capital Management Inc. bought a new position in shares of Merck KGaA during the second quarter worth about $2,095,000. Diversify Advisory Services LLC acquired a new stake in shares of Merck KGaA in the 2nd quarter worth about $3,810,000. Danske Bank A S bought a new stake in Merck KGaA in the 2nd quarter valued at about $276,535,000. Danica Pension Livsforsikringsaktieselskab acquired a new position in Merck KGaA during the 2nd quarter valued at about $25,541,000. Finally, BOK Financial Private Wealth Inc. bought a new position in Merck KGaA in the 2nd quarter worth about $523,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $162.12 on Friday. The firm’s 50 day moving average is $162.47 and its two-hundred day moving average is $148.35. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The firm has a market capitalization of $20.95 billion, a P/E ratio of 24.75 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
